http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34952863

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 73
issn 0929-1903
1476-5500
issueIdentifier 1
pageRange 62-73
publicationName Cancer Gene Therapy
startingPage 62
bibliographicCitation Liu X, Zhang J, Ju S, Liu L, Sun Y, Guo L, Zhen Q, Han S, Lu W, Zhang Y. ECT2 promotes malignant phenotypes through the activation of the AKT/mTOR pathway and cisplatin resistance in cervical cancer. Cancer Gene Ther. 2023 Jan;30(1):62–73. doi: 10.1038/s41417-022-00525-7. PMID: 36056253.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72d614e79bcf910059cfe760e49b23d9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47aec106cf5a2f1b4754a9f5338c2444
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92a50544b7a0b0931054b5d033cc7773
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17c94263094d08c428292159ea25ff18
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11dc0f0dadcc2279d0fe53f6c9ffaecb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7fc8bf572ed6e77a03abdfd55d4b420
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6132-141X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97781fb36c7cd754fbd856d65449cc5d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62049033c9ae677fa950ffee40fe4cc4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f46b6ae30ae70abafc460bdb091cfaa5
date 2022-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/36056253
https://doi.org/10.1038/s41417-022-00525-7
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8745
https://portal.issn.org/resource/ISSN/0929-1903
https://portal.issn.org/resource/ISSN/1476-5500
language English
source https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title ECT2 promotes malignant phenotypes through the activation of the AKT/mTOR pathway and cisplatin resistance in cervical cancer
discusses http://id.nlm.nih.gov/mesh/M0467915
http://id.nlm.nih.gov/mesh/M0543256
http://id.nlm.nih.gov/mesh/M0004505
http://id.nlm.nih.gov/mesh/M0017909
http://id.nlm.nih.gov/mesh/M0150739
http://id.nlm.nih.gov/mesh/M0469193
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9abf5b6b0d7926bde415bb32561343fd

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1894

Total number of triples: 46.